Belinda R. Avalos

Belinda R. Avalos

Hematology | Oncology
1021 Morehead Medical Drive
Building 2, Suite 60201
Charlotte, NC 28204

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

HMA/VEN: A New Pretransplant Paradigm for SOME People with AML.

HMA/VEN: A New Pretransplant Paradigm for SOME People with AML.

Journal: Transplantation and cellular therapy
Published: May 20, 2026

Pretransplant Conditioning for Hematopoietic Cell Transplants: The Past Is Prologue.

Pretransplant Conditioning for Hematopoietic Cell Transplants: The Past Is Prologue.

Journal: Transplantation and cellular therapy
Published: May 05, 2025

Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice.

Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice.

Journal: JCO oncology practice
Published: November 18, 2024

Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: July 15, 2024

American Society of Hematology: building a comprehensive minority recruitment and retention professional program.

American Society of Hematology: building a comprehensive minority recruitment and retention professional program.

Journal: Blood advances
Published: April 29, 2024

Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma.

Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma.

Journal: Transplantation and cellular therapy
Published: April 29, 2024

Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: March 08, 2024

Hereditary chronic neutrophilic leukemia in a four-generation family without transformation to acute leukemia.

Hereditary chronic neutrophilic leukemia in a four-generation family without transformation to acute leukemia.

Journal: American journal of hematology
Published: February 27, 2024

TP53 upregulation via aurora kinase inhibition overcomes primary failure to venetoclax in BCL2-rearranged lymphomas.

TP53 upregulation via aurora kinase inhibition overcomes primary failure to venetoclax in BCL2-rearranged lymphomas.

Journal: iScience
Published: January 31, 2024

Transplantation and cellular therapy in acute leukemia.

Transplantation and cellular therapy in acute leukemia.

Journal: Best practice & research. Clinical haematology
Published: August 23, 2023

Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.

Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.

Journal: The pharmacogenomics journal
Published: May 17, 2023

Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy.

Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy.

Journal: Experimental hematology
Published: February 28, 2023
Showing 1-12 of 40

Last Updated: 09/26/2026